Postpartum constipation and functional bloating due to pelvic floor/lifestyle changes.

Slowed intestinal motility and digestive "heaviness" linked to aging.

Severely immunocompromised individuals or those with acute gastrointestinal obstruction.

• Acceleration of Colonic Transit Time:
  Clinically proven to speed up the movement of food through the digestive tract, reducing constipation.
• Reduction of Functional Gastrointestinal Symptoms:
  Significant decrease in frequency of bloating, abdominal pain, and flatulence.
• Restoration of Bowel Regularity:
  Improvement in stool consistency and frequency (based on the Bristol Stool Scale).

HN019 Strain →

Metabolic Interaction: Increases the production of Short-Chain Fatty Acids (SCFAs). →

Peristalsis Stimulation: Modulates signaling to the enteric nervous system to promote gut motility. →

Pathogen Defense: Enhances the intestinal mucosal barrier and outcompetes "bad" bacteria. →

Result: Faster Intestinal Transit and a lighter, comfortable digestive feel.

• Dose-Response: Efficacy is highly dose-dependent; higher doses (approx. 10 billion CFU) show significantly faster transit results.
• Evidence Concentration: Results are most consistent in populations with existing functional constipation.
• Duration: Improved regularity is typically observed within 14 days of daily consumption.